Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Pathway for the Treatment of Multifocal Lung Adenocarcinoma Using Genome Sequencing

NCT01946100 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01946100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01946100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Pathway for the Treatment of Multifocal Lung Adenocarcinoma Using Genome Sequencing
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
November 6, 2013
Completion date
May 29, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, carcinoma non-small-cell lung, lung neoplasms